by introduction of secondary aliphatic ( e.g . isopropyl or secondary butyl ) ether groups into acyclic nucleosides such as aciclovir and ganciclovir new lipophilic prodrugs with modified physical and improved pharmacokinetic properties have been obtained .
C0001367
aciclovir
C0017066
ganciclovir